The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- BRAIN AG Acquires Majority Share of Analyticon Discovery (2014-07-03)
New company alliance with a leading international role in active compounds for health and nutrition Biotechnology company BRAIN and natural product specialist AnalytiCon Discovery GmbH have formed a unique partnership in the rapidly growing health and nutritio...
- Roche to Acquire Seragon Pharmaceuticals for up to $1.725b (2014-07-02)
Acquisition of Phase I program offers a potential new approach for hormone receptor-positive breast cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Genentech, a member of the Roche Group, has entered into a definitive agreement to acquire Serago...
- Roche Launches cobas 6500 Fully Automated Urine Analyzer (2014-06-30)
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of cobas® 6500, a fully automated urine testing system that consists of two modular analyzers combining urine strip testing and digital urinary microscopy. The system tests for 23 parameters to help diag...
- Mologen Updates on Positive Long-term Results for MGN1703 (2014-06-30)
> Two presentations at ESMO WCGI 2014 > Three MGN1703 patients still progression-free > Pivotal IMPALA trial to start recruitment Two posters about the cancer immune therapy MGN1703 of the biotechnology company MOLOGEN AG have been presented at the ESMO...
- Illumina Expands Access to Prenatal Testing Across Europe (2014-06-30)
Illumina, Inc. (NASDAQ:ILMN) today announced that it has entered into separate agreements with Biomnis, Genoma, and the Center for Human Genetics and Laboratory Diagnostics Martinsried, under which they will use the HiSeq 2500 and consumables from Illumina to devel...
- Affimed Files Registration Statement for IPO at Nasdaq in US (2014-06-30)
Affimed Therapeutics today announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering of its common shares. The number of shares to be offered and the pric...
- Roche: CHMP Recommends Avastin for Recurrent Ovarian Cancer (2014-06-27)
> Avastin is the first biologic medicine to receive a CHMP positive opinion for the most difficult to treat form of ovarian cancer > The positive opinion is based on a pivotal phase III study showing that the addition of Avastin to chemotherapy reduced the risk ...
- Roche Partners with and Invests in Stratos Genomics (2014-06-26)
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today, it made a strategic investment in Stratos Genomics and entered into a research collaboration to support further development of their unique chemistry applied to single molecule sequencing of DNA fragments using pr...
- Bruker MALDI Biotyper Gets Medical Device Approval in China (2014-06-25)
Bruker Corporation (NASDAQ: BRKR) today announced that it has received clearance from the China Food and Drug Administration (CFDA) to market and sell its IVD MALDI Biotyper System as a medical device in China for the identification of microorganisms isolated from ...
- Merck Serono and Mersana to Develop Antiobdy-Drug Conjugates (2014-06-24)
> Collaboration and license agreement allows Merck Serono to expand its oncology drug portfolio > Mersana Therapeutics' Fleximer technology to be leveraged to create multiple antibody-drug conjugates Merck Serono, the biopharmaceutical division of Merck, an...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to email@example.com and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)